Safety and efficacy of sirollmus-elutlng stent in patients with acute coronary syndrome undergoing emergency procedure

Circulation Journal

Volumn 72, Issue 7, 2008, Pages 1054-1058

  Nomoto, Kazumiki ^a   Watanabe, Ikuyoshi ^a,b   Oba, Tomiya ^a   Nagao, Ken ^c   Kushiro, Toshio ^a   Hirayama, Atsushi ^c  

^a Kawaguchi Municipal Medical Center   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndrome; Percutaneous coronary intervention (PCI); Sirolimus eluting stent

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; HEPARIN; RAPAMYCIN; TICLOPIDINE; IMMUNOSUPPRESSIVE AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EMERGENCY SURGERY; FEMALE; HEART DEATH; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; STATISTICAL SIGNIFICANCE; THROMBOSIS; DISEASE FREE SURVIVAL; EMERGENCY HEALTH SERVICE; JAPAN; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 46849115612     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.1054     Document Type: Article

References (20)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with astandard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
3. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomized controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.
4. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115.
5. Nakazawa G, Tanabe K, Aoki J, Onuma Y, Yamamoto H, Higashikuni Y, et al. Clinical and angiographic outcomes of sirolimus-eluting stent implantation in Japanese patients in daily practice. Circ J 2006; 70: 1367-1371.
6. Grines CL, Cox DA, Stone GW, Garcia E, Mattos L, Giambartolomei A, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction: Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-1956.
7. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al. Controlled Abximab and Device Investigation to Lower Late Angioplasty Complication (CADILLAC) investigators: Comparison of angioplasty with stenting, with or without abximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-966.
8. Fragmin and Fase Revascularization during Instability in Coronary artery disease (FRISC-II) Investigators. Invasive compared with noninvasive treatment in unstable coronary disease. Lancet 1999; 354: 708-715.
9. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al; Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomized trial: Randomized Intervention Trial unstable Angina. Lancet 2002; 360: 743-751.
10. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, et al for the TYPHOON investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093-1104.
11. Laarman GJ, Suttorp MJ, Dirksen MT, Heerebeek LV, Keimeneij F, Slagboom T, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006; 355: 1105-1113.
12. Braunwald E. Classification of unstable angina. Circulation 1989; 80: 410-414.
13. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
14. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
15. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double blind, randomized controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.
16. Morice MC, Colombo A, Meier B, Serruys P, Tamburio C, Guagliumi G, et al. Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions: The REALITY trial: A randomized controlled trial. JAMA 2006; 295: 895-904.
17. Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, et al. Tirofoban and sirolimus-eluting stent vs abximab and bare-metal stent for acute myocardial infarction: A randomized trial. JAMA 2005; 293: 2109-2117.
18. Takeyasu N, Watanabe S, Noguchi Y, Ishikawa K, Fumikura Y, Yamaguchi I. Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting. Circ J 2005; 69: 780-785.
19. Fukushima K, Kobayashi Y, Okuno T, Nakamura Y, Sakakibara M, Nakayama T, et al. Incidence of side-effect of ticropidine after sirolimus-eluting stent implantation: Retrospective analysis from three hospitals. Circ J 2007; 71: 617-619.
20. Popma JJ, Leon MB, Moses JW, Holmes DR, Cox N, Fitzpatrick M, et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004; 110: 3773-3780.